It suggested that ITGAV may contribute to creating a conducive environment for tumor growth, dissemination, and metastasis by regulating the infiltration of CAFs, thereby informing the development of clinically effective new treatments for digestive system cancers. This evidence concerns the gene ITGAV and neoplasm.